[Effects of 2 doses of lysine acetylsalicylate on platelet aggregation, beta-thromboglobulin and platelet factor 4 in aged atherosclerotic patients]. 1988

B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010978 Platelet Factor 4 A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C. Antiheparin Factor,CXCL4 Chemokine,Chemokine CXCL4,Heparin Neutralizing Protein,PF4 (Platelet Factor 4),gamma-Thromboglobulin,CXCL4, Chemokine,Chemokine, CXCL4,gamma Thromboglobulin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
June 1978, Minerva cardioangiologica,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
December 1984, Thrombosis and haemostasis,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
June 1987, Rinsho byori. The Japanese journal of clinical pathology,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
January 1983, Sangre,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
January 1993, Fetal diagnosis and therapy,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
January 1984, Acta haematologica,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
September 1994, Thrombosis and haemostasis,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
June 1985, Clinical pharmacology and therapeutics,
B Roussel, and J Delobel, and J Sangosse, and J Dieval, and J F Claisse, and J Lienard
January 1984, The American journal of pediatric hematology/oncology,
Copied contents to your clipboard!